187 related articles for article (PubMed ID: 35737245)
1. Using CRISPR-Cas9 to Dissect Cancer Mutations in Cell Lines.
Sayed S; Sürün D; Mircetic J; Sidorova OA; Buchholz F
Methods Mol Biol; 2022; 2508():235-260. PubMed ID: 35737245
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 as a tool to dissect cancer mutations.
Sayed S; Paszkowski-Rogacz M; Schmitt LT; Buchholz F
Methods; 2019 Jul; 164-165():36-48. PubMed ID: 31078796
[TBL] [Abstract][Full Text] [Related]
3. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology.
Mahato RK; Bhattacharya S; Khullar N; Sidhu IS; Reddy PH; Bhatti GK; Bhatti JS
J Biotechnol; 2024 Jan; 379():98-119. PubMed ID: 38065367
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 for cancer research and therapy.
Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
[TBL] [Abstract][Full Text] [Related]
5. The use of CRISPR/Cas9-based gene editing strategies to explore cancer gene function in mice.
van der Weyden L; Jonkers J; Adams DJ
Curr Opin Genet Dev; 2021 Feb; 66():57-62. PubMed ID: 33429291
[TBL] [Abstract][Full Text] [Related]
6. Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing.
Sayed S; Sidorova OA; Hennig A; Augsburg M; Cortés Vesga CP; Abohawya M; Schmitt LT; Sürün D; Stange DE; Mircetic J; Buchholz F
Cancer Res; 2022 Sep; 82(17):3002-3015. PubMed ID: 35802645
[TBL] [Abstract][Full Text] [Related]
7. Progression and application of CRISPR-Cas genomic editors.
Yang L; Tang J; Ma X; Lin Y; Ma G; Shan M; Wang L; Yang Y
Methods; 2021 Oct; 194():65-74. PubMed ID: 33774156
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
[TBL] [Abstract][Full Text] [Related]
9. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
10. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
12. Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing.
Aquino-Jarquin G
Mol Genet Metab; 2021; 134(1-2):77-86. PubMed ID: 34391646
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Cas9: A cornerstone for the evolution of precision medicine.
Razzouk S
Ann Hum Genet; 2018 Nov; 82(6):331-357. PubMed ID: 30014471
[TBL] [Abstract][Full Text] [Related]
16. CRISPR technology for immuno-oncology applications.
Wang J; Balan V; Marincola F
Methods Enzymol; 2020; 635():251-266. PubMed ID: 32122549
[TBL] [Abstract][Full Text] [Related]
17. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
19. [Genome engineering using the CRISPR-Cas9 system and applications in cancer research].
Hudacsek V; Gyõrffy B
Magy Onkol; 2018 Jul; 62(2):119-127. PubMed ID: 30027940
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects.
Kaligotla VSA; Jasti T; Kandra P
Biotechnol Appl Biochem; 2022 Jun; 69(3):1238-1251. PubMed ID: 34033692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]